Overview

A Itraconazole Effect Study of SHR2554 on Healthy Chinese Adult Subjects

Status:
Completed
Trial end date:
2020-10-01
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to evaluate the effect of Itraconazole on pharmacokinetics of healthy Chinese adult subjects after oral administration of SHR2554 tablets. The secondary objective of the study is to evaluate the safety of single dose of SHR2554 orally in healthy subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Jiangsu HengRui Medicine Co., Ltd.
Treatments:
Itraconazole